{
    "nctId": "NCT01898312",
    "briefTitle": "BRCA1/2 and Effect of Mifepristone on the Breast",
    "officialTitle": "The Effect of a Progesterone Receptor Modulator on Breast Tissue in Women With BRCA-1 and -2 Mutations - a Placebo Controlled RCT.",
    "overallStatus": "COMPLETED",
    "conditions": "Women With Mutations in the Breast Cancer Susceptibility Genes BRCA1,2",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "PREVENTION",
    "enrollmentCount": 45,
    "primaryOutcomeMeasure": "epithelial cell proliferation in breast tissue",
    "eligibilityCriteria": "Inclusion criteria:\n\n* Pre-menopausal women, \\>/= 18 years of age\n* with good general health and\n* regular menstrual cycles (25-35 days) who are willing and\n* able to participate after giving informed consent.\n* women having BRCA1/2 mutation and have decided to undergo risk reducing mastectomy\n\nExclusion criteria includes:\n\n* Any hormonal treatment used within 2 months prior to study start and\n* Any contraindication to mifepristone",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}